Skip to content

Clinical trials

Overweight trials in Sweden

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Overweight Country / region: Sweden Clear all

58 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20051
20062
20071
20083
20102
20112
20121
20131
20143
20151
20162
20172
20182
20195
20204
20214
20221
20234
20242
20256
20268

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed28
Recruiting14
Active, not recruiting5
Unknown status5
Terminated2
Not yet recruiting2
Enrolling by invitation1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Karolinska Institutet12
Novo Nordisk A/S5
Vastra Gotaland Region4
Chalmers University of Technology3
Empros Pharma AB3
Linkoeping University3
AstraZeneca2
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.2
Lund University2
Region Örebro County2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Overweight58
Obesity47
Diabetes Mellitus, Type 26
Hypertension6
Metabolic Syndrome4
Weight Loss4
Body Weight3
Cardiovascular Diseases3
Glucose Intolerance3
Metabolic Diseases3

Trials

Showing 76 to 58 of 58. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.